NEWTON, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Auron Therapeutics, a biotechnology company focused on developing next-generation targeted therapies by identifying and treating disrupted cell states ...
NEWTON, Mass., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Auron Therapeutics, a clinical-stage biotechnology company targeting cell-state plasticity to improve patient outcomes in oncology and inflammatory ...
AUTX-703 has demonstrated potent growth inhibition in preclinical models of solid tumors and a hematological malignancy An overview of the Company’s AURIGIN platform to be presented at the American ...
An overview of the Company’s AURIGIN platform to be presented at the American Association for Cancer Research (AACR) 2024 Annual Meeting NEWTON, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Auron ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback